Xianghui Li

Title: Xianghui Li: Innovator in High Fidelity Restriction Endonucleases

Introduction

Xianghui Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of high fidelity restriction endonucleases. With a total of 7 patents to his name, his work has had a substantial impact on genetic engineering and molecular biology.

Latest Patents

Among his latest patents, Xianghui Li has developed methods and compositions for engineering mutant enzymes with reduced star activity. These mutant enzymes exhibit a fidelity index (FI) in a specified buffer that is greater than that of the non-mutated enzyme in the same buffer. This innovation enhances the precision of genetic modifications, making it a valuable tool for researchers in the field.

Career Highlights

Xianghui Li has worked with notable companies, including New England Biolabs, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking advancements in biotechnology.

Collaborations

Xianghui Li has collaborated with esteemed colleagues such as Zhenyu Zhu and Aine Quimby. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Xianghui Li's contributions to the field of biotechnology, particularly through his patents on high fidelity restriction endonucleases, highlight his role as a leading inventor. His work continues to influence the landscape of genetic engineering and molecular biology.